Literature DB >> 8841319

Cerebral venous thrombosis and activated protein C resistance.

D A Dulli1, C C Luzzio, E C Williams, H S Schutta.   

Abstract

BACKGROUND: Activated protein C resistance (APC-R) due to factor V Leiden has recently been established as an important risk factor for cerebral venous thrombosis (CVT). The clinical significance of abnormal or borderline functional APC-R in the absence of factor V Leiden is uncertain. Our observations suggest that APC-R due to mechanisms other than factor V Leiden may also contribute to the development of CVT. CASE DESCRIPTIONS: We describe three women who had superior sagittal and lateral sinus thrombosis while taking oral contraceptives and had a number of additional risk factors for CVT. Each had APC-R for different reasons.
CONCLUSIONS: Inherited thrombophilia, including APC-R, should be looked for in all patients with CVT. Functional APC-R is a highly prevalent coagulopathy, but the reasons for this abnormality are diverse; abnormal and borderline functional APC-R results should be supplemented by DNA analysis for the presence of factor V Leiden.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8841319     DOI: 10.1161/01.str.27.10.1731

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  8 in total

Review 1.  Is there an increased risk of stroke associated with oral contraceptives?

Authors:  K Zeitoun; B R Carr
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

Review 2.  Antithrombotic therapy for stroke in young adults.

Authors:  Jeremy R Payne; Bruce Coull
Journal:  J Thromb Thrombolysis       Date:  2005-10       Impact factor: 2.300

3.  Superior sagittal sinus thrombosis: a clinical and experimental study.

Authors:  H Nakase; T Takeshima; T Sakaki; A Heimann; O Kempski
Journal:  Skull Base Surg       Date:  1998

4.  Isolated cortical venous thrombosis after fetal demise.

Authors:  Mohammad Al-Jundi; Ghassan Al-Shbool; Mohamad Muhailan; Moutasem Aljundi; Christian J Woods
Journal:  BMJ Case Rep       Date:  2019-04-29

Review 5.  Thyroid, hemostasis and thrombosis.

Authors:  F Marongiu; C Cauli; S Mariotti
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

6.  Incidental discovery of a dural arteriovenous fistula in a patient with activated protein C resistance.

Authors:  Jason D Wenderoth; Constantine C Phatouros
Journal:  AJNR Am J Neuroradiol       Date:  2003-08       Impact factor: 3.825

Review 7.  Acquired pial and dural arteriovenous fistulae following superior sagittal sinus thrombosis in patients with protein S deficiency: a report of two cases.

Authors:  Shunji Matsubara; Koichi Satoh; Junichiro Satomi; Toshio Shigekiyo; Tomoya Kinouchi; Hajimu Miyake; Shinji Nagahiro
Journal:  Neurol Med Chir (Tokyo)       Date:  2013-10-25       Impact factor: 1.742

8.  Factor V Leiden, factor V Cambridge, factor II GA20210, and methylenetetrahydrofolate reductase in cerebral venous and sinus thrombosis: A case-control study.

Authors:  Mohammad Saadatnia; Mansour Salehi; Ahmad Movahedian; Seyed Ziaeddin Samsam Shariat; Mehri Salari; Marzieh Tajmirriahi; Elham Asadimobarakeh; Rasoul Salehi; Gilda Amini; Homa Ebrahimi; Ehsan Kheradmand
Journal:  J Res Med Sci       Date:  2015-06       Impact factor: 1.852

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.